Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the feasibility of intranasal ketamine for adequate sedation of children undergoing minor procedures in the Emergency Department. An intranasal dose of 10mg/kg...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Arizona
NCT04490031 · Ketamine Adverse Reaction
NCT03525912 · Pain, Postoperative, Ketamine Adverse Reaction
NCT01731106 · Critical Illness, Complication of Ventilation Therapy, and more
NCT02878837 · Failed Moderate Sedation During Procedure, Minimally Conscious State
NCT02732132 · Failed Moderate Sedation During Procedure
Banner Univsersity Medical Center Tucson
Tucson, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions